SequelSEC

Cartesian Growth Corp II RENEF

Blank Checks · CIK 0001889112 · Fiscal year ends 1231

Revenue
Unavailable
Fiscal year ended 2025-12-31
Operating income
-$931.46K
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

Valuation, from the filing

Public float$105.50MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

Valuation over time

21.8× earnings today, against a median of 21.8× across 3 years on record. In line with its own history.

Float measuredPublic floatFloat / net income
2024-06-28$178.90M21.8×
2023-06-30$245.40M21.4×
2022-06-30$230.50M46.8×

Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.

How this compares in its industry

Percentile among the Blank Checks filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio0.06x20th

Cartesian Growth Corp II (RENEF) reported net income of -$1.51M for the fiscal year ended 2025-12-31. This page shows 4 annual periods of income statement, balance sheet and cash flow figures normalized from Cartesian Growth Corp II’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Blank Checks.

Income

Cartesian Growth Corp II income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
RevenueUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailable
Operating income-$931.46K-$1.04M-$2.03M-$685.06K
Net income-$1.51M$8.21M$11.44M$4.93M
Research & developmentUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesUnavailableUnavailableUnavailableshares 5.75M
Pretax incomeUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailable
Diluted EPSUnavailableUnavailableUnavailable$0.24
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailable
General & administrativeUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailable

Balance

Cartesian Growth Corp II balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Cash & equivalentsUnavailableUnavailableUnavailableUnavailable
Total assets$38.28M$85.00M$174.58M$240.60M
Current assets$363.31K$438.85K$330.03K$850.40K
Total liabilities$26.71M$20.70M$18.87M$18.89M
Current liabilities$5.73M$3.48M$1.53M$218.91K
Total equity incl. NCI-$26.34M-$20.26M-$18.54M-$18.04M
Temporary (mezzanine) equityUnavailableUnavailableUnavailable$239.75M
InventoryUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailable

Cash flow

Cartesian Growth Corp II cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Operating cash flow-$773.85K-$814.23K-$922.74K-$842.88K
Capital expendituresUnavailableUnavailableUnavailableUnavailable
Investing cash flow$49.12M$97.81M$77.14M-$236.90M
Financing cash flow-$48.42M-$96.81M-$76.71M$238.29M
Net change in cash-$73.85K$185.77K-$492.74K$543.67K
Stock-based compensationUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailable
Common share repurchases$51.22M$99.61M$77.44MUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailable

Derived

Cartesian Growth Corp II derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailable
Current ratio0.06x0.13x0.22x3.88x
Revenue YoY growthUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open RENEF in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

Reconciliation checks needing review

3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2025-12-31

Difference 37914438 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.

balance equationreview2024-12-31

Difference 84565597 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.

balance equationreview2023-12-31

Difference 174252198 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.